- Home
- TILE vs SRPT Comparison
TILE vs SRPT Comparison
Compare TILE & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TILE | SRPT |
|---|---|---|
| Founded | 1973 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.4B |
| IPO Year | 1994 | 2000 |
Fundamental Metrics
Financial Performance| Metric | TILE | SRPT |
|---|---|---|
| Price | $31.58 | $18.12 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 28 |
| Target Price | ★ $36.00 | $25.76 |
| AVG Volume (30 Days) | 346.5K | ★ 2.3M |
| Earning Date | 01-01-0001 | 04-17-2026 |
| Dividend Yield | ★ 0.25% | N/A |
| EPS Growth | 94.74 | ★ 140.34 |
| EPS | ★ 1.55 | N/A |
| Revenue | $1,315,658,000.00 | ★ $1,901,979,000.00 |
| Revenue This Year | $7.55 | $14.67 |
| Revenue Next Year | $4.81 | N/A |
| P/E Ratio | $21.01 | ★ N/A |
| Revenue Growth | 4.29 | ★ 52.97 |
| 52 Week Low | $17.31 | $10.42 |
| 52 Week High | $35.11 | $109.55 |
Technical Indicators
Market Signals| Indicator | TILE | SRPT |
|---|---|---|
| Relative Strength Index (RSI) | 44.85 | 41.21 |
| Support Level | $25.59 | $17.05 |
| Resistance Level | $32.15 | $19.62 |
| Average True Range (ATR) | 1.13 | 1.00 |
| MACD | -0.33 | 0.03 |
| Stochastic Oscillator | 13.15 | 27.91 |
Price Performance
Historical ComparisonAbout TILE Interface Inc.
Interface Inc is engaged in the design, production, and sale of carpet tiles. It also provides Luxury Vinyl tiles and rubber flooring. The company mainly targets corporate and noncorporate office markets, including government, education, healthcare, hospitality, and retailers. Its geographical segments include the Americas, Europe, and Asia-Pacific. It has two operating and reportable segments- namely Americas (AMS) and Europe, Africa, Asia and Australia (collectively EAAA). Key revenue is generated from AMS segment.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.